Recognition of human renal cell carcinoma and melanoma by HLA-A2-restricted cytotoxic T lymphocytes is mediated by shared peptide epitopes and up-regulated by interferon-

Scandinavian Journal of Immunology

Volumn 44, Issue 3, 1996, Pages 285-292

  Bernhard, H ^a   Maeurer, M J ^b   Jager E ^c   Wolfel T ^a   Schneider, J ^a   Karbach, J ^c   Seliger, B ^a   Huber, C ^a   Storkus, W S ^b   Lotze, M T ^b   Meyer Zum Buschenfelde K H ^a   Knuth, A ^c  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c KRANKENHAUS NORDWEST   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HLA A2 ANTIGEN;

ARTICLE; CASE REPORT; CELL LINE; CYTOTOXIC T LYMPHOCYTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HLA SYSTEM; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MELANOMA; PRIORITY JOURNAL;

EID: 9444258556     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-304.x     Document Type: Article

References (42)

1. Gromet MA, Epstein WL, Blois MS. The regressing thin malignant melanoma: a distinctive lesion with metastatic potential. Cancer 1978;42:2282-92.
2. De Kernion J, Rammig K, Smith R. The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 1978;120:148-52.
3. Knuth A, Danowski B, Oettgen HF, Old LJ. T-cell mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin-2-dependent T-cell cultures. Proc Natl Acad Sci USA 1984;81:3511-15.
4. Belldegrun A, Muul LM, Rosenberg SA. Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization and antitumor activity. Cancer Res 1988;48:201-14.
5. Knuth A, Wölfel T, Klehmann E, Boon T, Meyer zum Büschenfelde KH. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection. Proc Natl Acad Sci USA 1989;86:2804-8.
6. + T cell line. J Immunother 1992;11:1-11.
7. Schendel DJ, Gansbacher B, Oberneder R et al. Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. J Immunol 1993;151:4209-20.
8. Van den Eynde B, Hainaut P, Herin M et al. Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int J Cancer 1989;44:634-40.
9. Wölfel T, Hauer M, Klehmann E et al. Distinct shared antigens in human melanoma recognized in association with HLA-A2 and defined by cytotoxic T lymphocyte (CTL) clones. Int J Cancer 1993;55:237-44.
10. + tumor-infiltrating lymphocytes. J Immunol 1994; :1202-15.
11. Anichini A, Maccalli C, Motarini R et al. Melanoma cells and normal melanocytes share antigens recognized by HLA-A2-restricted cytotoxic T cell clones from melanoma patients. J Exp Med 1993;177:989-98.
12. Brichard V, van Pel A, Wölfel T et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993;178:489-95.
13. Cox AL, Skipper J, Chen Y et al. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. Science 1994;264:716-9.
14. Houghton AN. Cancer antigens: immune recognition of self and altered self. J Exp Med 1994;180:1-4.
15. Coulie PG, Brichard V, van Pel A et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994;180:35-42.
16. Kawakami Y, Eliyahu S, Delgado CH et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 1994;91:3515-19.
17. Bakker AB, Schreurs MW, de Boer AJ et al. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med 1994;179:1005-9.
18. Bernhard H, Karbach J, Wölfel T et al. Cellular immune response to human renal cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T lymphocytes (CTL) clones. Int J Cancer 1994;59:1-6.
19. Carrel S, Johnson PJ. Immunologic recognition of malignant melanoma by autologous T lymphocytes. Curr Opin Oncol 1993;5:383-9.
20. Wölfel T, Klehmann E, Müller C et al. Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens. J Exp Med 1989;170:297-810.
21. Townsend A, Bodmer H. Antigen recognition by class I-restricted T lymphocytes. Ann Rev Immunol 1989;7:601-24.
22. Rötzschke O, Falk K, Deres K et al. Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells. Nature 1990;348:252-4.
23. Slingluff CL Jr, Cox AL, Stover JM Jr et al. Cytotoxic T-Lymphocyte response to autologous human squamous cell cancer of the lung: epitopes reconstitution with peptides extracted from HLA-Aw68. Cancer Res 1994;54:2731-7.
24. Nakao M, Yamana H, Imai Y et al. HLA A2601-restricted CTLs recognize a peptide expressed on squamous cell carcinoma. Cancer Res 1995;55:4248-52.
25. Storkus WJ, Zeh HJ III, Maeurer MJ, Salter RD, Lotze MT. Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes. J Immunol 1993;151:3719-27.
26. Wölfel T, Schneider J, Meyer zum Büschenfelde K-H et al. Isolation of naturally processed peptides recognized by cytolytic T lymphocytes (CTL) on human melanoma cells in association with HLA-A2.1. Int J Cancer 1994;57:413-8.
27. Salter RD, Howell DN, Cresswell P. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids. Immunogenetics 1985;21:235-46.
28. McMichael AJ, Parham P, Rust N, Brodsky FM. A monoclonal antibody (Tue 48) defining alloantigeneic class I determinants specific for HLA-Bw4 and HLA-Aw23, Aw24. as well as -Aw32. Hum Immunol 1980;5:269-81.
29. Bodmer H, Ogg G, Gotch F, McMichael A. Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes. Nature 1989;342:443-6.
30. Brodsky FM, Parham P, Barn CJ, Crumpton MJ, Bodmer WF. Monoclonal antibodies for analysis of the HLA system. Immunol Rev 1979;47:342-51.
31. Restifo NP, Esquivel F, Kawakumi Y et al. Identification of human cancers deficient in antigen processing. J Exp Med 1993;177:265-72.
32. Seliger B, Höhne A, Knuth A et al. Analysis of the MHC class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression. Cancer Res 1996;56:1756-60.
33. Ernsthoff MS, Trautman T, Davis CA. A randomized phase I/II study of cutaneous versus intermittent intravenous Interferon gamma in patients with melastatic malignant melanoma. J Clin Oncol 1987;5:1804.
34. Aulitzky W, Gastl G, Aulitzky WE et al. Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma. J Clin Oncol 1989;7:1875-84.
35. Kawakami Y, Eliyahu S, Delgado CH et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 1994;91:6458-62.
36. + cytotoxic T lymphocytes. J Exp Med 1995;181:363-8.
37. Bartholomew JS, Stacey SN, Coles B et al. Identification of a naturally processed HLA A0201-restricted viral peptide from cells expressing human papilloma virus type 16 E6 oncoprotein. Eur J Immunol 1994;24:3175-9.
38. van der Bruggen P, Traversari C, Chomez P et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991;254:1643-7.
39. Zitvogel L, Mayordomo JI, Tjandrawan T et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation. and T helper cell 1-associated cytokines. J Exp Med 1996;183:87-97.
40. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNFalpha cooperate in the generation of dendritic Langerhans cells. Nature 1992;360:258-61.
41. Bernhard H, Disis ML, Heimfeld S et al. Generation of immunostimulatory dendritic cells from human CD34 + hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res 1995;55:1099-1104.
42. Szabolcs P, Moore MAS, Young JW. Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. J Immunol 1995;154:5851-61.